These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6700599)

  • 21. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
    Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
    Lab Delo; 1978; (5):259-66. PubMed ID: 79007
    [No Abstract]   [Full Text] [Related]  

  • 23. [Correlation of fragmented cells with lytic products and other hematologic data].
    Rodríguez-Cerrillo Ríos GA; Lepe Zúñiga JL
    Bol Med Hosp Infant Mex; 1981; 38(2):243-9. PubMed ID: 7259845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of internal hemorrhage on fibrin(ogen) degradation products in canine blood.
    McCaw DL; Jergens AE; Turrentine MA; Johnson GS
    Am J Vet Res; 1986 Jul; 47(7):1620-1. PubMed ID: 3740635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
    Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
    Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Level of fibrinogen/fibrin degradation products (F/FDP) in certain internal diseases].
    Alakhverdian R; Denchev K
    Vutr Boles; 1979; 18(4):28-32. PubMed ID: 494629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fibrinogenderivatives in plasma and serum of newborn infants with respiratory distress syndrome].
    Lenk H; Weissbach G; Braun W; Domula M; Vogtmann C
    Acta Paediatr Acad Sci Hung; 1976; 17(2):135-46. PubMed ID: 1032734
    [No Abstract]   [Full Text] [Related]  

  • 29. Significance of increased fibrin/fibrinogen degradation products and presence of fibrin monomers in pregnant women.
    Svanberg L; Eydal A; Astedt B
    Ann Chir Gynaecol Suppl; 1977; 66(5):247-50. PubMed ID: 596808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fibrin and fibrinogen degradation products in head- and neck-tumors (author's transl)].
    Wilmes EH; Hochstrasser K
    Laryngol Rhinol Otol (Stuttg); 1978 Dec; 57(12):1083-6. PubMed ID: 732487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [FDP in newborn period. Especially the FDP and fibrin monomers in respiratory distress syndrome of premature infants].
    Yamada K; Shirahata A; Meguro T; Nakazawa S
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):646-50. PubMed ID: 4677381
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of FDP].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1985 Feb; Spec No 61():86-96. PubMed ID: 3889425
    [No Abstract]   [Full Text] [Related]  

  • 33. A rapid turbidimetric determination of fibrinogen degradation products (FDP).
    Verbruggen HW; Wessels JM
    Thromb Haemost; 1978 Feb; 39(1):12-21. PubMed ID: 580487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of blood fibrinogen (fibrin) degradation products by reaction to hemagglutination delay of sensitized erythrocytes].
    Ponizovskiĭ MP; Tsynkalovskaia SN
    Vrach Delo; 1976 Aug; (8):115-7. PubMed ID: 1020269
    [No Abstract]   [Full Text] [Related]  

  • 35. [An immunonephelometric micromethod of determining the levels of fibrin-fibrinogen degradation products].
    Ivanov EP; Tsvirko DG
    Lab Delo; 1989; (10):12-5. PubMed ID: 2481061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative sensitivity of different methods to detect and quantify circulating fibrinogen/fibrin split products.
    Drewinko B; Surgeon J; Cobb P; Callahan L; Schmidt D; Bollinger P; Trujillo JM
    Am J Clin Pathol; 1985 Jul; 84(1):58-66. PubMed ID: 3893094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Standarization of the staphylococcal clumping test (SCT) for the detection of fibrinogen/fibrin degradation products (FDP) in serum (author's transl)].
    Contreras P; Salazar R
    Rev Med Chil; 1975 Aug; 103(8):551-4. PubMed ID: 1197971
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical utility of serum fibrinogen degradation products (FDP) in the diagnostic and prognostic evaluation of oral cancer.
    Ghosh M; Aroor AR; Raghavan MR
    Ann Dent; 1990; 49(2):11-2, 45. PubMed ID: 2278474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DIC screening in the newborn.
    Pugh M
    Neonatal Netw; 1997 Oct; 16(7):57-60. PubMed ID: 9369697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations on properdin activity in the mature and premature newborns with the intrauterine infection.
    Woytoń J; Gajewska E; Riess A; Rudnicka M
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):67-70. PubMed ID: 7149927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.